Hyamed Unveils Exciting New Products Including CaHA and PLLA at IMCAS 2024

Hyamax®, the brand under Switzerland's Laboratories Hyamed SA, has been a leader in the non-invasive medical aesthetics market, focusing on hyaluronic acid dermal fillers and mesotherapy for years.

At IMCAS 2024, Hyamax® shows CaHA and PLLA, two hot favorites in the regenerative dermal filler market. This highlights Hyamed's robust research and development capabilities and its ambition in the regenerative medical aesthetics field.

Additionally, Hyamax® presents its mesotherapy product series, addressing various facial, body, and scalp concerns with targeted solutions. With effective ingredients and scientific formulations, each drop of Hyamax® mesotherapy products embodies the ultimate fusion of science and aesthetics by research experts.

Hyamax® Unveils Monophasic Cross-Linked Hyaluronic Acid Filler Volumizer and Non-Cross-Linked Hyaluronic Acid Filler Super Hydra, showcasing Hyamed's expertise beyond the traditional biphasic hyaluronic acid domain. 

In March, Hyamed will showcase its innovations at the glamorous AMWC in Monaco and Cosmoprof Bologna in Italy. Connect with us for more details and discover the beauty of Hyamed!